Pharmacovigilance: reporting requirements throughout a product's lifecycle.

Area of Science:

• Pharmacology
• Drug Safety
• Regulatory Science

Background:

• Robust drug safety evaluation is essential for assessing medication risk profiles.
• Provider confidence in drug safety and effectiveness is paramount for patient care.
• Pharmacovigilance is a critical component of regulatory processes ensuring medication safety.

Purpose of the Study:

• To provide an overview of pharmacovigilance and drug safety post-authorization in the United States.
• To examine US Food and Drug Administration (FDA) guidance and post-approval regulatory actions.
• To consider drug safety from an industry perspective.

Main Methods:

• Narrative review of pharmacovigilance and drug safety literature.
• Analysis of FDA guidance and post-approval regulatory actions.
• Examination of industry perspectives on drug safety.

Main Results:

• Comprehensive safety evaluation methods are needed for objective risk assessment.
• Active engagement of healthcare providers and consumers enhances pharmacovigilance.
• Post-approval monitoring and regulatory actions are key to ongoing drug safety.

Conclusions:

• Pharmacovigilance is vital for ensuring the long-term safety of medications.
• Collaboration among healthcare stakeholders improves the identification and management of drug risks.
• Understanding FDA regulations is crucial for industry in maintaining drug safety.